US FDA approves Merck’s injectable version of blockbuster cancer therapy Keytruda Reuters FDA OKs New Keytruda Shot for Cancer The New York Times FDA Approves Subcutaneous Pembrolizumab for Solid Tumors OncLive Merck wins approval of subcutaneous Keytruda, in bid to extend life of world’s top-selling drug Endpoints News Merck Wins US Approval of Easier-to-Use Version of Cancer Drug Keytruda Bloomberg.com Source link
Read More »